Independent validation of CT radiomics models in colorectal liver metastases: predicting local tumour progression after ablation - Summary - MDSpire

Independent validation of CT radiomics models in colorectal liver metastases: predicting local tumour progression after ablation

  • By

  • Denise J. van der Reijd

  • Corentin Guerendel

  • Femke C. R. Staal

  • Milou P. Busard

  • Mateus De Oliveira Taveira

  • Elisabeth G. Klompenhouwer

  • Koert F. D. Kuhlmann

  • Adriaan Moelker

  • Cornelis Verhoef

  • Martijn P. A. Starmans

  • Doenja M. J. Lambregts

  • Regina G. H. Beets-Tan

  • Sean Benson

  • Monique Maas

  • November 21, 2023

  • 0 min

Share

Objective:

To validate clinical-radiomics prediction models for local tumour progression (LTP) after thermal ablation of colorectal liver metastases (CRLM) using independent internal and external validation cohorts, highlighting the importance of generalizability.

Key Findings:
  • The combined clinical-radiomics model showed a concordance statistic of 0.78 (95% CI 0.65–0.87) in predicting LTP, indicating a moderate level of predictive accuracy.
  • Internal and external validation confirmed the applicability of the prediction models to different patient populations, suggesting robustness in diverse clinical settings.
Interpretation:

The study supports the use of radiomics in predicting LTP after thermal ablation of CRLM, potentially allowing for timely intervention in high-risk patients.

Limitations:
  • The internal validation cohort was limited in size due to a short inclusion period.
  • Exclusion criteria adjustments may affect the generalizability of results.
  • Potential biases in patient selection due to the retrospective nature of the study should be acknowledged.
Conclusion:

The validated clinical-radiomics models can aid in predicting LTP after thermal ablation, improving patient management strategies.

Original Source(s)

Related Content